Key statistics
On Friday, Century Therapeutics Inc (IPSC:NSQ) closed at 1.21, 6.14% above its 52-week low of 1.14, set on Oct 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.22 |
---|---|
High | 1.27 |
Low | 1.20 |
Bid | 1.20 |
Offer | 1.21 |
Previous close | 1.24 |
Average volume | 460.01k |
---|---|
Shares outstanding | 85.03m |
Free float | 60.89m |
P/E (TTM) | -- |
Market cap | 105.44m USD |
EPS (TTM) | -1.86 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
- Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
- Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
- Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
- Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
- Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
- Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
- Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
- Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
More ▼